In soft tissue sarcomas, CHEK1 serves as an unfavorable prognostic biomarker associated with immunosuppressive phenotypes, showing significant overexpression in immune-low tumors and correlating with altered patterns of tumor-infiltrating immune cells (67). Here, CHEK1 is linked to soft tissue sarcoma.